Login / Signup

Salvage resection plus cesium-131 brachytherapy durably controls post-SRS recurrent brain metastases.

Brandon S ImberRobert J YoungKathryn BealAnne S ReinerAlexandra M Giantini LarsenSimone KrebsJonathan T YangDavid Aramburu-NunezGil'ad N CohenCameron BrennanViviane TabarNelson S Moss
Published in: Journal of neuro-oncology (2022)
With > 1.5 years of follow-up, intraoperative brachytherapy with commercially available Cs131 implants was associated with favorable local control and toxicity profiles. Weak correlation between preoperative tumor geometry and implanted tiles highlights a need to optimize planning criteria.
Keyphrases
  • brain metastases
  • high dose
  • small cell lung cancer
  • radiation therapy
  • patients undergoing
  • locally advanced
  • low dose
  • oxidative stress
  • squamous cell carcinoma
  • rectal cancer